← Leaderboards
Brian K. Link
University Of Iowa
$2,190,894
Attributed
$2,190,894
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $692.5K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,190,894 · 11
By mechanism
P50$1,702,075 · 5
P30$484,771 · 4
M01$4,048 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Brian Joseph Smith$3,731,732
- George J Weiner$29,916,936
- Gregory Charles Gray$9,968,744
- Malik E Juweid$0
- Zuhair K Ballas$4,832,394
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsProtocols DocumentationResourcesSamplingEpidemiologyLymphomaTranslational ResearchFundingEnrollmentMemberLinkResearch Project GrantsMolecular EpidemiologyCohortCollaborationsIowaGeneticResearch PersonnelBloodDiagnosisMalignant NeoplasmsResource SharingTumor
Grant awards (24)
Project 4: Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma$441,654
P50 · FY2021 · CA · contact PI
Core D: Clinical$250,807
P50 · FY2021 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$71,519
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$7,201
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$6,879
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$4,902
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$3,646
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$1,699
P30 · FY2018 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$61,334
P30 · FY2017 · CA · contact PI
Cluster C: 9 Molecular Epidemiology Resource$77,551
P30 · FY2016 · CA · contact PI
Clinical Research$327,251
P50 · FY2009 · CA · contact PI
Clinical Trials Support Core$152,472
P30 · FY2009 · CA · contact PI
Clinical Research$336,099
P50 · FY2008 · CA · contact PI
Clinical Research$346,264
P50 · FY2007 · CA · contact PI
CLINICAL TRIALS SUPPORT CORE$97,568
P30 · FY2005 · CA
CPG 7909 IN PATIENTS WITH B-CELL NON-HODGKIN'S LYMPHOMA$4,048
M01 · FY2004 · RR
CORE--CLINICAL TRIALS$0
P50 · FY2002 · CA
EFFECTOR CELLS AND ANTILYMPHOMA ANTIBODY THERAPY$0
P50 · FY2002 · CA
Core--Clinical trials support group$0
P30 · FY2002 · CA
HU 1D10 MAB IN RELAPSED NON-HODGKIN'S LYMPHOMA (NHL)$0
M01 · FY2002 · RR
Core--Clinical trials support group$0
P30 · FY2001 · CA
HU 1D10 MAB IN RELAPSED NON-HODGKIN'S LYMPHOMA (NHL)$0
M01 · FY2001 · RR
Core--Clinical trials support group$0
P30 · FY2000 · CA
HU 1D10 MAB IN RELAPSED NON-HODGKIN'S LYMPHOMA (NHL)$0
M01 · FY2000 · RR